Previous Article | Next Article 
J Virol, July 1998, p. 6260-6263, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Coreceptor Usage of Human Immunodeficiency Virus Type 2 Primary
Isolates and Biological Clones Is Broad and Does Not Correlate with
Their Syncytium-Inducing Capacities
Christophe
Guillon,1
Marchina E.
van der
Ende,1,2
Patrick H. M.
Boers,1
Rob A.
Gruters,1,3
Martin
Schutten,1 and
Albert
D. M. E.
Osterhaus1,*
Institute of Virology, Erasmus University
Rotterdam,1 and
Department of Internal
Medicine, University Hospital Dijkzigt,2
Rotterdam, The Netherlands, and
UMR 103 CNRS/bioMérieux, Ecole Normale Supérieure de Lyon, Lyon,
France3
Received 9 February 1998/Accepted 15 April 1998
Entry of human immunodeficiency virus type 1 (HIV-1) into target
cells is mediated by binding of the surface envelope glycoprotein to
the CD4 molecule. Interaction of the resulting CD4-glycoprotein complex
with
- or
-chemokine receptors, depending on the biological phenotype of the virus, then initiates the fusion process. Here, we
show that primary HIV-2 isolates and biological clones, in contrast to
those of HIV-1, may use a broad range of coreceptors, including CCR-1,
CCR-3, CCR-5, and CXCR-4. The syncytium-inducing capacity of these
viruses did not correlate with the ability to infect via CXCR-4 or any
other coreceptor. One cell-free passage of the intermediate isolates in
mitogen-stimulated, CD8+ cell-depleted peripheral blood
mononuclear cells resulted in the outgrowth of variants with CCR-5
only, whereas the coreceptor usage of late and early isolates did not
change. Since HIV-2 is less pathogenic in vivo than HIV-1, these data
suggest that HIV pathogenicity in vivo is not directly related to the
spectrum of coreceptors used in in vitro systems.
*
Corresponding author. Mailing address: Institute of
Virology, Erasmus University Rotterdam, Dr. Molewaterplein 50, P.O.
Box 1738, 3000 DR Rotterdam, The Netherlands. Phone: (31) 10 408 8066. Fax: (31) 10 436 5145. E-mail:
osterhaus{at}viro.fgg.eur.nl
J Virol, July 1998, p. 6260-6263, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Del Prete, G. Q., Haggarty, B., Leslie, G. J., Jordan, A. P. O., Romano, J., Wang, N., Wang, J., Holmes, M. C., Montefiori, D. C., Hoxie, J. A.
(2009). Derivation and Characterization of a Simian Immunodeficiency Virus SIVmac239 Variant with Tropism for CXCR4. J. Virol.
83: 9911-9922
[Abstract]
[Full Text]
-
Soares, R., Foxall, R., Albuquerque, A., Cortesao, C., Garcia, M., Victorino, R. M. M., Sousa, A. E.
(2006). Increased Frequency of Circulating CCR5+ CD4+ T Cells in Human Immunodeficiency Virus Type 2 Infection. J. Virol.
80: 12425-12429
[Abstract]
[Full Text]
-
Blaak, H., Boers, P. H. M., Gruters, R. A., Schuitemaker, H., van der Ende, M. E., Osterhaus, A. D. M. E.
(2005). CCR5, GPR15, and CXCR6 Are Major Coreceptors of Human Immunodeficiency Virus Type 2 Variants Isolated from Individuals with and without Plasma Viremia. J. Virol.
79: 1686-1700
[Abstract]
[Full Text]
-
Clapham, P. R., McKnight, A.
(2002). Cell surface receptors, virus entry and tropism of primate lentiviruses. J. Gen. Virol.
83: 1809-1829
[Abstract]
[Full Text]
-
Reeves, J. D., Doms, R. W.
(2002). Human immunodeficiency virus type 2. J. Gen. Virol.
83: 1253-1265
[Full Text]
-
Schutten, M., van Baalen, C. A., Guillon, C., Huisman, R. C., Boers, P. H. M., Sintnicolaas, K., Gruters, R. A., Osterhaus, A. D. M. E.
(2001). Macrophage Tropism of Human Immunodeficiency Virus Type 1 Facilitates In Vivo Escape from Cytotoxic T-Lymphocyte Pressure. J. Virol.
75: 2706-2709
[Abstract]
[Full Text]
-
Schramm, B., Penn, M. L., Palacios, E. H., Grant, R. M., Kirchhoff, F., Goldsmith, M. A.
(2000). Cytopathicity of Human Immunodeficiency Virus Type 2 (HIV-2) in Human Lymphoid Tissue Is Coreceptor Dependent and Comparable to That of HIV-1. J. Virol.
74: 9594-9600
[Abstract]
[Full Text]
-
Zhang, Y.-j., Lou, B., Lal, R. B., Gettie, A., Marx, P. A., Moore, J. P.
(2000). Use of Inhibitors To Evaluate Coreceptor Usage by Simian and Simian/Human Immunodeficiency Viruses and Human Immunodeficiency Virus Type 2 in Primary Cells. J. Virol.
74: 6893-6910
[Abstract]
[Full Text]
-
Owen, S. M., Masciotra, S., Novembre, F., Yee, J., Switzer, W. M., Ostyula, M., Lal, R. B.
(2000). Simian Immunodeficiency Viruses of Diverse Origin Can Use CXCR4 as a Coreceptor for Entry into Human Cells. J. Virol.
74: 5702-5708
[Abstract]
[Full Text]
-
Kokkotou, E. G., Sankale, J.-L., Mani, I., Gueye-Ndiaye, A., Schwartz, D., Essex, M. E., Mboup, S., Kanki, P. J.
(2000). In vitro correlates of HIV-2-mediated HIV-1 protection. Proc. Natl. Acad. Sci. USA
97: 6797-6802
[Abstract]
[Full Text]
-
van der Ende, M. E., Guillon, C., Boers, P. H. M., Gruters, R. A., Racz, P., Tenner-Racz, K., Osterhaus, A. D. M. E., Schutten, M.
(2000). Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model. J. Gen. Virol.
81: 507-513
[Abstract]
[Full Text]
-
Reeves, J. D., Hibbitts, S., Simmons, G., McKnight, A., Azevedo-Pereira, J. M., Moniz-Pereira, J., Clapham, P. R.
(1999). Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates Infect CD4-Negative Cells via CCR5 and CXCR4: Comparison with HIV-1 and Simian Immunodeficiency Virus and Relevance to Cell Tropism In Vivo. J. Virol.
73: 7795-7804
[Abstract]
[Full Text]